found that selective cyclooxygenase inhibitors inhibit MDR1 expression and P-glycoprotein in taxane-resistant ovarian cancer, thus sensitizing cells to paclitaxel (114). The gene discussed is ABCB1; the disease is ovarian carcinoma.